The Current Ratio as of September 2024 (TTM) for Procaps Group S.A. (PROC) is 1.47

According to Procaps Group S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 1.47. This represents a change of 26.71% compared to the average of 1.16 of the last 4 quarters.

Procaps Group S.A. (PROC) Historical Current Ratio (quarterly & annually)

How has PROC Current Ratio performed in the past?

The mean historical Current Ratio of Procaps Group S.A. over the last ten years is 0.96. The current 1.47 Current Ratio has changed 15.14% with respect to the historical average. Over the past ten years (40 quarters), PROC's Current Ratio was at its highest in in the December 2021 quarter at 1.59. The Current Ratio was at its lowest in in the March 2020 quarter at 0.03.

Procaps Group S.A. (PROC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Procaps Group S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Procaps Group S.A. (PROC) Average Current Ratio

How has PROC Current Ratio performed in the past?

The current Current Ratio of Procaps Group S.A. (PROC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Procaps Group S.A. (PROC) Current Ratio vs. Peers

How is PROC’s Current Ratio compared to its peers?

Procaps Group S.A.’s Current Ratio is less than Silver Spike Investment Corp. (0), less than Sihuan Pharmaceutical Holdings Group Ltd. (6.09), less than Phibro Animal Health Corporation (1.64), less than Eagle Pharmaceuticals, Inc. (2.94), less than Delta 9 Cannabis Inc. (2.16), greater than RAMM Pharma Corp. (0.30), less than City View Green Holdings Inc. (0), greater than Craftport Cannabis Corp. (0.01), greater than Speakeasy Cannabis Club Ltd. (0.03), greater than Collegium Pharmaceutical, Inc. (1.40), greater than ANI Pharmaceuticals, Inc. (1.11), less than Prestige Consumer Healthcare Inc. (3.97), less than Regencell Bioscience Holdings Limited (3.23), less than null (19.15),

Build a custom stock screener for Procaps Group S.A. (PROC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Procaps Group S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Procaps Group S.A. (PROC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Procaps Group S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.